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Conﬁrmation of Linkage to Chromosome 1q for Peak Vertebral Bone
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Peak bone mineral density (BMD) is a highly heritable trait and is a good predictor of the risk of osteoporosis and
fracture in later life. Recent studies have sought to identify the genes underlying peak BMD. Linkage analysis in
a sample of 464 premenopausal white sister pairs detected linkage of spine BMD to chromosome 1q (LOD 3.6).
An independent sample of 254 white sister pairs has now been genotyped, and it also provides evidence of linkage
to chromosome 1q (LOD 2.5) for spine BMD. Microsatellite markers were subsequently genotyped for a 4-cM
map in the chromosome 1q region in all available white sister pairs ( ), and a LOD score of 4.3 wasnp 938
obtained near the marker D1S445. Studies in the mouse have also detected evidence of linkage to BMD phenotypes
in the region syntenic to our linkage ﬁnding on chromosome 1q. Thus, we have replicated a locus on 1q contributing
to BMD at the spine and have found further support for the region in analyses employing an enlarged sample.
Studies are now ongoing to identify the gene(s) contributing to peak spine BMD in women.
Introduction
Osteoporosis is major public health problem, producing
disability and excess mortality through the development
of fractures. It is a disease characterized by low bone
mass and microarchitectural deterioration of bone tis-
sue, leading to enhanced bone fragility and a consequent
increase in fracture risk (World Health Organization
Consensus Development Conference 1991). In the Unit-
ed States, as many as 54% of postmenopausal white
women, or ∼17 million women, have low bone mass,
and another 20%–30%, or 6–9 million, have osteopo-
rosis (Melton et al. 1992; Melton 1995; Looker et al.
1997). Vertebral compression fractures are common os-
teoporotic fractures and lead to pain, deformity, and
disability. Low bone mineral density (BMD) is a major
contributing factor. BMD in later life is highly correlated
with peak BMD in the 3rd or 4th decade of life. Sex and
race are also important predictors of peak BMD, with
men and African Americans having higher average peak
BMD than women and whites, respectively (Bell 1997),
as well as a concomitantly lower rate of osteoporosis and
fracture (Bohannon et al. 1999).
There is a strong genetic component to peak spine
BMD (Peacock et al. 2002). Indeed, a variety of study
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designs indicate that as much as 80% of the variability
in peak BMD is attributable to genetic factors. Despite
the substantial heritability of peak BMD, variability in
this phenotype is still likely to be due to the effects of
multiple, interacting genes. Several studies have also
suggested greater phenotypic similarity among individ-
uals of the same sex in a family (Jones and Nguyen
2000; Duncan et al. 2003; Van Pottelberg et al. 2003).
Identiﬁcation of the genes underlying spine BMD will
be important in understanding the underlying mecha-
nisms of bone formation and maintenance and may elu-
cidate the mode of action of sex-speciﬁc QTLs. This, in
turn, may provide molecular targets for future therapies
for osteoporosis.
We previously performed an autosomal genome
screen in 429 premenopausal white sister pairs and
found evidence of linkage of peak spine BMD to mark-
ers on chromosome 1q (LOD 3.11) (Koller et al. 2000).
Additional genotyping in an expanded sample of 464
white sister pairs increased the LOD score to 3.64 at
marker D1S484 (Koller et al. 2000). The goals of the
current study were to replicate our previous spine BMD
linkage results by performing a 10-cM genome screen
in an independent sample of 254 premenopausal white
sister pairs, ascertained and evaluated using procedures
identical to those used for our previously analyzed sam-
ple. In this independent sample, we have replicated link-
age of spine BMD to chromosome 1q. Subsequently, all
available white sister pairs ( ) and their parentsnp 938
( ) were genotyped for a denser set of micro-np 316
satellite markers in the chromosome 1q region, to fur-
ther delineate the critical chromosomal interval. Our
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results provide signiﬁcant evidence of the existence of a
gene(s) on chromosome 1q that affects peak spine BMD.
Methods
Subjects
As in our previous studies, healthy, premenopausal
sister pairs between the ages of 20 and 50 years were
recruited through advertisement to participate in studies
designed to identify genes contributing to bone-related
phenotypes. Sibships of more than two individuals were
actively recruited. When available, parents of the pre-
menopausal sister pairs were requested to contribute a
blood sample for DNA extraction. All studies were per-
formed at the General Clinical Research Center at In-
diana University Medical School, and all subjects gave
written, informed consent prior to participation. The
study was approved by the Indiana University institu-
tional review board.
Sisters have been continually recruited since 1995, and
molecular studies were performed as sufﬁcient samples
became available for analysis. As a result, a genome
screen was previously completed in 429 sister pairs
(Koller et al. 2000), and a genome screen was more
recently completed in a subsequent sample of 254 in-
dependent sister pairs. Additional sisters and their par-
ents have continued to be recruited (255 sister pairs).
Therefore, to maximize the power of molecular studies
to localize genetic effects, all available samples from
these additional sister pairs and their parents were in-
cluded in the follow-up genotyping on chromosome 1q
(938 sister pairs and 316 parents).
BMD
BMD was measured by dual energy X-ray absorp-
tiometry (DPX-L [Lunar Corporation]) at lumbar ver-
tebrae L2–L4. Sisters were measured on the same ma-
chine, usually at the same visit. Image analysis was
performed using version 4.6/4.7 of the software. The
coefﬁcient of variation for the lumbar spine, measured
in 20 women who had duplicate BMD measurements
made after they were repositioned on the machine, was
0.52%. Height and weight were measured using a Har-
penden Stadiometer and a Scale-Tronix weighing scale,
which were regularly calibrated throughout the study.
DNA and Marker Genotyping
DNA was isolated using standard techniques and was
stored in a DNA repository under a unique code. A 10-
cM genome scan was performed at the Center for In-
herited Disease Research by use of automated ﬂuorescent
microsatellite analysis. PCR products were sized on an
ABI 3700 sequencer. The marker set was a modiﬁcation
of version 9 of the Cooperative Human Linkage Center
(CHLC) marker set, with 392 markers at an average
spacing of 9 cM and an average heterozygosity of 0.76.
The error rate based on paired genotypes from blind
duplicate samples was 0.1%. The overall missing-data
rate was 5.7%. The marker genotype data from the ge-
nomewide screen was used to verify full-sibling rela-
tionships among subjects by use of the computer pro-
grams RELATIVE (Go¨ring and Ott 1997) and RELPAIR
(Boehnke and Cox 1997), and half-sibling pairs were
eliminated from further analysis.
To maximize the power to further localize the genes
contributing to spine BMD, additional genotyping by
use of microsatellite repeat markers on chromosome 1q
was performed on all available samples from white sub-
jects (938 sister pairs). This enlarged sample included all
individuals who were genotyped as part of either of the
two genome screens (683 sister pairs), as well as the 35
sister pairs who were genotyped only in the selected
chromosomal region (Koller et al. 2000) and those re-
cruited after the initiation of the second genome screen
(220 sister pairs). Since 180% of the subjects recruited
for the sample were white and this subsample provided
the greatest evidence of linkage to chromosome 1q, only
white subjects were included in the denser microsatellite-
marker genotyping. For recently recruited subjects who
were not part of either genome screen, the full-sibling
relationships were conﬁrmed by analyzing 10 X-chro-
mosome markers.
A total of 14 markers were genotyped in the chro-
mosome 1q linkage region. All markers were selected
from the Marshﬁeld map on the basis of their reported
heterozygosity and marker position, with a preference
for tetranucleotide repeat markers, when available. The
average intermarker distance in the chromosome 1q crit-
ical interval delimited by D1S2777 and D1S2823 was
4 cM, and the average marker heterozygosity was 76%.
PCR products were sized on an ABI 3100 by use of the
Genotyper program, version 3.6, with overreading by
two independent observers. Chromosomal positions,
marker order, and map positions were obtained from the
Marshﬁeld electronic database (Marshﬁeld Center for
Medical Genetics Web site).
Quantitative Linkage Analysis
Stepwise regression analysis was employed with the
spine BMD phenotype, and height, weight, oral contra-
ceptive use, pack-years of smoking, and age were used
to identify signiﬁcant covariates with spine BMD. Re-
gression residuals, representing covariate-adjusted BMD
values, were computed and used in all analyses. Mul-
tipoint quantitative linkage analysis was performed for
BMD by use of the maximum-likelihood variance-esti-
mation method, as implemented in the computer pack-
age Mapmaker/SIBS (Kruglyak and Lander 1995). Using
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Table 1
Characteristics of Participants in Study
SAMPLE
NO. OF
PARTICIPANTS
NO. OF
FAMILIES
NO. OF SIBLING PAIRS MEAN  SD
Independent All Possible
Age of Participant
(years)
Difference in
Sibling Age
(years)
Weight of
Participant
(kg)
Lumbar (L2–L4)
Spine BMD
(g/cm2)
Independent 365 164 201 254 32.6  7.1 3.8  2.4 68.4  15.2 1.28  0.13
Expanded 1,342 602 740 938 33.2  7.1 3.7  2.4 69.4  16.0 1.28  0.14
all possible sibling pairs formed from families with more
than two sisters, LOD scores were computed at 1-cM
intervals along each autosome. Observed allele frequen-
cies in the individuals genotyped for the genome screen
were used. To conﬁrm the robustness of linkage, analyses
were also performed using only independent sibling pairs
and implementing the more conservative Haseman-Els-
ton regression approach (Kruglyak and Lander 1995).
Results
A sample of 254 independent white sister pairs was as-
certained and evaluated to detect linkage to the phe-
notype of spine BMD. The mean age of the sister pairs
was 32.6 years, and the mean difference in age between
sisters was 3.8 years (table 1). Of the covariates studied
for their effect on spine BMD, only age and weight ap-
proached signiﬁcance ( ) in stepwise model ﬁtting.P ! .10
Residuals from regressionmodel ﬁtting were used as age-
and weight-adjusted spine BMD values in all subsequent
analyses.
A genome screen in the independent sample of 254
white sister pairs did not identify any chromosomal re-
gion with a LOD score 13.6, the typically employed
threshold for genomewide signiﬁcance (Lander and
Kruglyak 1995). However, linkage to chromosome 1q
with a LOD score of 2.5 was detected in the same chro-
mosomal region identiﬁed in our ﬁrst linkage study
(Koller et al. 2000), with a peak slightly distal to the
original peak. Thus, linkage to the chromosome 1q re-
gion was replicated by our independent sample on the
basis of the criteria (LOD 1 1.2) of Lander andKrugylak
(1995). No other chromosomal region had a LOD score
11.3 in our sample of 254 white sister pairs.
Additional genotyping of microsatellite markers was
performed in the chromosome 1q region that was re-
ported in both of our independent linkage samples. To
maximize power, all available white sister pairs and
their parents were genotyped. The analysis of these 938
sister pairs and their 316 parents resulted in a LOD
score of 4.3 at position 181 cM on the Marshﬁeld map
(ﬁg. 1). Since spine BMD is calculated from the bone
mineral content (BMC) of the vertebra divided by its
area, we also performed linkage analysis with BMC and
area to determine if either of these phenotypes was re-
sponsible for our observed linkage with spine BMD.
The multipoint LOD score for vertebral BMC was 2.8,
with the peak in approximately the same position as
the peak for BMD. There was no evidence for linkage
with bone area, suggesting that the evidence for linkage
to peak spine BMD in our sample does not result from
an effect on bone size.
Discussion
In our ﬁrst linkage study (Koller et al. 2000), we detected
signiﬁcant evidence of linkage of spine BMD to chro-
mosome 1q21-23 with a LOD score of 3.6. In the current
work, we performed a genomewide linkage scan in an
independent sample of 254 white sister pairs, to identify
chromosomal regions that harbor genes that affect peak
spine BMD in premenopausal women. In this replication
study, only one chromosomal region produced a LOD
score 11.3 when analyzing the highly heritable spine
BMD phenotype. This LOD score of 2.5 occurred at
chromosome 1q22-23. Although the LOD-score graph
of the current study substantially overlaps with the re-
sults of our original linkage study (Koller et al. 2000),
the two ﬁgures are not superimposable. However, given
the imprecision of linkage methods for localizing the
contributory gene(s) (Roberts et al. 1999), we have
strong evidence that we have replicated our signiﬁcant
linkage ﬁnding in an independent sample.
As noted above, spine BMD is calculated from the
BMC of the vertebra divided by its area. Therefore, it
was possible that our linkage ﬁndings resulted from
differences in vertebral size between individuals rather
than variation in spine BMD. To exclude this possibility,
we performed the same analysis but designated BMC
and vertebral area as phenotypes. Our results indicate
that the observed linkage ﬁndings result from a gene(s)
affecting spine BMD rather than bone size.
We performed further analyses with microsatellite
markers on chromosome 1q in an expanded group of
938 premenopausal white women, a group that in-
cluded all white women from both genome screens in
addition to newly ascertained samples. We have focused
our molecular studies on only the white families for
several reasons. First, although our initial analyses
(Koller et al. 2000) found that the inclusion of African
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Figure 1 Multipoint linkage results for chromosome 1 in the sample of white subjects in the study by Koller et al. (2000) (dashed line),
the independent sample of white subjects (thin line), and the expanded sample of white subjects (thick line). The position of the centromere is
indicated by a dark circle.
American sister pairs increased our LOD score on chro-
mosome 1q, further marker genotyping in additional
samples suggest that the 131 African American families
in our study do not provide strong evidence of linkage
to this region of chromosome 1q. Second, numerous
studies of complex disease-related phenotypes have
found that different susceptibility genes may be segre-
gating in samples of various ancestry (Cox 2001; Ful-
lerton et al. 2002). Therefore, it is quite possible that
some of the genes contributing to the variation in spine
BMD in the white sister pairs may not manifest a strong
effect in samples from other racial groups. This hy-
pothesis is further supported by the well-known racial
differences in BMD (Bell et al. 1991). Thus, tomaximize
our power to further localize the gene(s) contributing
to variation in peak spine BMD, we elected to limit our
analyses to only the white sister pairs, who represent
the single largest racial group in our sample.
Further marker genotyping in the chromosome 1q13-
31 region was performed to achieve an average inter-
marker distance under the linkage peak of ∼4 cM. This
resulted in some narrowing of the critical interval; how-
ever, the region remains broad, encompassing many po-
tential candidate genes. This region of chromosome 1q
contains several candidate genes, including the struc-
tural gene for osteocalcin, the interleukin-6 receptor
gene, and a group of genes encoding the calcium-bind-
ing proteins. Linkage to chromosome 1q23.3-q24 has
been reported for hypercalciuria, a common cause of
kidney stones (Reed et al. 1999), which is frequently
accompanied by reduced vertebral bone density
(Pietschmann et al. 1992). Recently, polymorphisms in
the soluble adenylate cyclase gene have been reported
to contribute to hypercalciuria and low spine BMD
(Reed et al. 2002).
Multiple studies in mouse models have linked BMD
phenotypes to the syntenic region of human chromo-
some 1, which is mouse chromosome 1. Strong evidence
of linkage to mouse chromosome 1 was observed for
both spine and femur BMD in female C57BL/6J#C3H/
HeJ F2 animals (Beamer et al. 2001; Koller et al., in
press). Klein and colleagues reported linkage of whole-
body BMD to mouse chromosome 1, initially using re-
combinant inbred lines derived from C57BL/6J and
DBA/2 mice (Klein et al. 1998) and later conﬁrmed in
an F2 sample created from a cross of the same two
progenitor lines (Klein et al. 2001). In addition, a study
of a different cross employing C57BL/6J#CAST/EiJ F2
mice detected linkage to the same region of mouse chro-
mosome 1 by use of the phenotype of peak femoral
BMD, as measured by peripheral quantitative computed
tomography (pQCT) (Beamer et al. 1999). Unfortu-
nately, vertebral BMD was not measured in that study.
Although the linkage we found to chromosome 1q
has also been observed in all mouse studies of similar
BMD phenotypes, human studies of BMD have not con-
sistently reported linkage to this region. A comparison
of the various sample designs and phenotyping methods
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employed in human family studies highlights several
important differences from our own unique study of
peak spine BMD measured in premenopausal women.
First, unlike our study and that of Spector and col-
leagues (Wilson et al. 2003), most study designs have
included both males and females (Devoto et al. 1998;
Niu et al. 1999; Karasik et al. 2002). On the basis
of the recent observation of sex-speciﬁc QTLs in mouse
models (Orwoll et al. 2001) and human studies sug-
gesting greater phenotypic similarity among same-sex
individuals (Jones and Nguyen 2000; Duncan et al.
2003; Van Pottelberg et al. 2003), it is quite likely that
studies of both sexes may identify unique QTLs as com-
pared with those samples that focus solely on women.
Second, our sample includes only premenopausal
women and therefore is designed to identify genes con-
tributing to peak BMD. All other studies have sampled
individuals across a wide age range, encompassing not
only peak BMD but also bone loss as well as bone
acquisition. The limited number of studies that have
been performed to date have been quite inconclusive
regarding the genetic contribution to bone loss (Chris-
tian et al. 1989; Kelly et al. 1993), and no study has
yet demonstrated that the same genes contribute to peak
BMD and bone loss. Therefore, the genes that will be
identiﬁed in studies encompassing individuals from a
wide age range are likely to be different from those
linked to the highly heritable phenotype of peak BMD
in premenopausal women.
In summary, we performed a genomewide linkage
scan for spine BMD in an independent sample and
found evidence for linkage to markers on chromosome
1q. Subsequently, we genotyped markers to a 4-cM den-
sity in an expanded sample of 938 white sister pairs.
Our results indicate that this region harbors a gene(s)
that inﬂuences peak BMD in premenopausal white
women and that the gene(s) on chromosome 1q may
affect BMD in both mice and humans. These studies
represent an important step in identifying the genes un-
derlying normal variation in BMD.
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